Your browser does not support JavaScript!
Logo de FierceBiotech

FierceBiotech Source d'actualité

Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

Novartis inks $2.1B Endocyte buyout, furthering radiotherapy push

Il y a 2 jours
Novartis has struck a $2.1 billion (€1.8 billion) deal to acquire Endocyte. The deal caps off a whirlwind year for Endocyte, which licensed the cancer drug that caught Novartis’ eye for $12 million...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 15:43

Amgen buys $66M stake in pocket-sized DNA sequencer maker Oxford Nanopore

Il y a 2 jours
Amgen has invested $66 million (£50 million) into portable genome sequencer developer Oxford Nanopore. The Big Pharma hopes the investment will align with its efforts in using genomics to inform its...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 14:05

Gilead, Aelix ally to trial HIV-suppressing combination

Il y a 2 jours
Gilead has teamed up with Aelix Therapeutics to trial a combination designed to free people with HIV from the need to take antiretroviral drugs. The planned clinical trial will test Gilead’s TLR7...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 11:52

Ziopharm’s R&D head joins Spectrum as CMO

Il y a 2 jours
Ziopharm Oncology’s executive vice president of R&D, Francois Lebel, M.D., is moving to cancer drugmaker Spectrum Pharmaceuticals to serve as its chief medical officer effective Nov. 5....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 07:36

After putting £35M into MiNA Therapeutics, Sosei passes on buyout option

Il y a 2 jours
In May 2017, Sosei invested £35 million in MiNA Therapeutics with an option to buy the RNA biotech out. Now, the Tokyo-based company is passing on that option, giving up the right to acquire MiNA in...
www.fiercebiotech.com
Charger plus d'actualités

Informations juridiques

SIREN / SIRET USA Washington, DC

Adresse

Washington DC USA- Washington, DC Etats-Unis

Equipes

Je travaille dans cette entreprise